Analysis of Molecular and Immunohematology Blood Typing and Grouping and Infectious Disease NAT Screening Assays 2015 - Strategic Assessments of Current and Emerging Suppliers

Nov 18, 2015, 14:10 ET from Research and Markets


DUBLIN, Nov. 18, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/rg5pwn/2015_analysis_of) has announced the addition of the "2015 Analysis of Molecular and Immunohematology Blood Typing, Grouping and Infectious Disease NAT Screening Assays, and Strategic Profiles of Leading Suppliers" report to their offering.

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. 

Companies Mentioned

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • CellMark Forensics/LabCorp
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Immucor
  • Ortho-Clinical Diagnostic
  • Proteome Sciences
  • Quest
  • Quidel
  • Roche
  • Siemens
  • Tecan
  • Thermo Fisher/Life Technologies

For more information visit http://www.researchandmarkets.com/research/rg5pwn/2015_analysis_of

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com